An Open-label, Long-Term Safety and Tolerability Trial of Lumateperone in the Treatment of Pediatric Patients With Schizophrenia or Bipolar Disorder

Conditions: Schizophrenia; Bipolar Disorder Interventions: Drug: Lumateperone Sponsors: Intra-Cellular Therapies, Inc. Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials